PALLD antibody (N-Term)
Quick Overview for PALLD antibody (N-Term) (ABIN302145)
Target
See all PALLD AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- N-Term
-
Purpose
- Palladin
-
Sequence
- SLSDMQEESK NTD
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence SLSDMQEESKNTD-C, from the N Terminus of the protein sequence according to NP_057165.3.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: Preliminary experiments in Human Liver, Heart and Ovary lysates gave no specific signal but low background (at antibody concentration up to 1 μg/mL). We would appreciate any feedback from people in the field - have any results been reported
Peptide ELISA: antibody detection limit dilution 1:2000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Alternative Name
- PALLD
-
Background
- PALDD, palladin, cytoskeletal associated protein, CGI-151, FLJ22190, FLJ38193, FLJ39139, KIAA0992, PNCA1, SIH002, palladin, sarcoma antigen NY-SAR-77
-
Gene ID
- 23022
-
NCBI Accession
- NP_057165
Target
-